written on 11.03.2014

Glycotope raises €55m for cancer drugs improved by human glycosylation


German biotech firm Glycotope, which uses its GlycoExpress platform to improve drugs and drug candidates through "human" glycosylation, has raised €55m for the development of its two lead cancer drug candidates, PankoMab-GEX and CetuGEX. Both are in…

Latest Reports